awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47651588-70EE5EE5-6675-4FF6-B0E3-3F1064214F41
Q47651588-70EE5EE5-6675-4FF6-B0E3-3F1064214F41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47651588-70EE5EE5-6675-4FF6-B0E3-3F1064214F41
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
P1476
Q47651588-70EE5EE5-6675-4FF6-B0E3-3F1064214F41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47651588-70EE5EE5-6675-4FF6-B0E3-3F1064214F41
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e325a555d9457ff73757b0d47e4839e22f44f9d
P1476
Tofacitinib improves pruritus
......
te to severe plaque psoriasis.
@en